Douglas B Given Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 19 hours ago
Douglas B Given has an estimated net worth of at least $10.0 million*, as of April 1, 2026. They own 137,167 shares of ARWR stock. They have sold 25,333 shares of ARWR stock since 2021, for an estimated $1.2 million.
Douglas B Given $ARWR SEC Form 4 Insider Trading
Douglas B Given has filed a total of 9 insider trades in $ARWR since 2021. Their most recent trade was a sale of 5,000 shares, made on Dec 16, 2024. Their largest trade was a sale of 6,500 shares, made on May 05, 2023. We estimate that they now own 137,167 shares of $ARWR, worth an estimated $8.8 million.
Insider Trading at $ARWR
There have been a total of 216 insider trades reported at $ARWR since 2021, with 3,655 shares purchased and 2.1 million shares sold. The most active insider traders in $ARWR stock have been Christopher Richard Anzalone, Patrick O'Brien, and Kenneth Allen Myszkowski. The most recent trade was a sale of 10,000 shares reported by James C Hamilton (Chief Medical Officer), made on Mar 05, 2026.
History of Insider Stock Trades by Douglas B Given
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ARWR
|
Sale | 5,000 | Dec 16, 2024 | Dec. 18, 2024, 7:18 p.m. |
|
ARWR
|
Sale | 547 | Dec 17, 2024 | Dec. 18, 2024, 7:18 p.m. |
|
ARWR
|
Sale | 1,100 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
ARWR
|
Sale | 1,811 | Jan 11, 2024 | Jan. 16, 2024, 7:06 p.m. |
|
ARWR
|
Sale | 6,500 | May 05, 2023 | May 8, 2023, 6:29 p.m. |
|
ARWR
|
Sale | 875 | Feb 27, 2023 | March 1, 2023, 7:14 p.m. |
|
ARWR
|
Purchase | 655 | Dec 28, 2021 | Dec. 29, 2021, 9:44 p.m. |
|
ARWR
|
Sale | 5,000 | Sep 09, 2021 | Sept. 9, 2021, 8 p.m. |
|
ARWR
|
Sale | 4,500 | Jun 22, 2021 | June 23, 2021, 8 p.m. |
$ARWR Executives and Stock Owners with Insider Trades
-
Christopher Richard Anzalone, Chief Executive Officer
-
Patrick O'Brien, COO and General Counsel
-
Kenneth Allen Myszkowski, Chief Financial Officer
-
James C Hamilton, Chief Medical Officer
-
Patrick O'Brien, COO
-
Martin Javier San, Chief Medical Officer
-
James C Hamilton, Chief Discovery/Trans Medicine
-
Patrick O'Brien, General Counsel
-
Tracie Oliver, Chief Commercial Officer
-
James Hassard, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.